Delivery Order SPE2DX22D0010-SPE2D825FFL08
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$4.9K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation. The $10,909.32 order is for 4,564,186,391 units of methylphenidate extended-release 27 mg tablets, a specialty pharmaceutical used to treat attention deficit hyperactivity disorder (ADHD). The delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,273.72 firm-fixed-price contract is for the delivery of 36 mg methylphenidate extended-release tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to...
This is a $1,012.64 delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Methylphenidate ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999, for delivering a comprehensive range of medical...
This is a $1,379.20 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of methylphenidate extended-release 36 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of April 9, 2025 and was awarded on April 8, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,293.70 firm-fixed-price contract is for the delivery of 100 tablets of 27 mg methylphenidate extended-release, a drug used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $2,875.43 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The order is for 100 tablets of 36 mg extended-release methylphenidate, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,042.36 firm fixed-price contract is for the supply of Methylphenidate ER 27 mg tablets, a medication used in the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract does not have a set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,681.22 firm-fixed-price delivery order is for the supply of 4,566,504,596 tablets of 27mg extended-release methylphenidate, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,414.83, is for the delivery of 18 mg extended-release methylphenidate tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a period of performance through October 24, 2024 and is structured as a firm fixed-price...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,213.23 firm fixed-price contract is for the delivery of 100 tablets of 27 mg extended-release methylphenidate, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a...